Pages that link to "Q1075324"
Jump to navigation
Jump to search
The following pages link to chlorpropamide (Q1075324):
Displaying 50 items.
- aspirin (Q18216) (← links)
- Potassium inwardly rectifying channel subfamily J member 11 (Q6414726) (← links)
- (Q10877092) (redirect page) (← links)
- ATP binding cassette subfamily C member 8 (Q21113671) (← links)
- ATP-binding cassette sub-family C member 8 (Q21137888) (← links)
- Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues (Q28265442) (← links)
- Chlorpropamide induced syndrome of inappropriate secretion of antidiuretic hormone (Q28325825) (← links)
- Chlorpropamide or chlorpromazine? (Q28328101) (← links)
- Postoperative hypoglycaemic coma associated with chlorpropamide (Q28340784) (← links)
- Chlorpropamide alcohol flush and circulating met-enkephalin: a positive link (Q28366117) (← links)
- Hepatotoxic reaction associated with metformin and chlorpropamide treatment (Q28374125) (← links)
- maturity-onset diabetes of the young type 2 (Q32147145) (← links)
- Thrombocytopenia in a patient taking chlorpropamide (Q33352649) (← links)
- Thrombocytopenia after treatment with metahexamide and chlorpropamide (Q33353437) (← links)
- THROMBOCYTOPENIA OCCURRING DURING CHLORPROPAMIDE THERAPY. (Q33354308) (← links)
- A CASE OF THROMBOCYTOPENIA ASSOCIATED WITH CHLORPROPAMIDE THERAPY (Q33355591) (← links)
- Chlorpropamide; a new hypoglycaemic agent (Q34539015) (← links)
- Hyponatraemia during treatment with chlorpropamide and Moduretic (amiloride plus hydrochlorothiazide) (Q34552998) (← links)
- Comparative bioavailability study with two chlorpropamide tablet formulations in healthy volunteers. (Q34584296) (← links)
- Severe hypoglycemia reactions following treatment with tolbutamide, carbutamide and chlorpropamide (report on 14 cases, studies on clinical symptoms and pathogenesis) (Q34705162) (← links)
- Epidemiological study of prevalence of chlorpropamide alcohol flushing in insulin dependent diabetics, non-insulin dependent diabetics, and non-diabetics (Q34709383) (← links)
- Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man. (Q34711157) (← links)
- Treatment of chlorpropamide overdose with diazoxide. (Q34713704) (← links)
- Chlorpropamide induced syndrome of inappropriate antidiuretic hormone secretion. (Q34716686) (← links)
- Diazoxide in the Management of Chlorpropamide Overdose (Q34717971) (← links)
- Stevens-Johnson syndrome and neutropenia with chlorpropamide therapy (Q34718460) (← links)
- Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome (Q35151102) (← links)
- Potentiation of the response to vasopressin (pitressin) by treatment with a combination of chlorpropamide and chlorothiazide in Brattleboro rats with hereditary hypothalamic diabetes insipidus (Q35176916) (← links)
- Oral hypoglycemic agents in the treatment of diabetes mellitus. A review of clinical experience with chlorpropamide, tolbutamide, and phenethvlbiguanide. (Q35358055) (← links)
- The effect of chlorpropamide on water balance in pitressin-treated Brattleboro rats (Q35601308) (← links)
- The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries. (Q35820260) (← links)
- Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism (Q35826971) (← links)
- Familial ADH-responsive diabetes insipidus: response to thiazides and chlorpropamide (Q35937590) (← links)
- The influence of chlorpropamide pre-treatment on insulin and growth hormone release after arginine (Q36770220) (← links)
- Abnormal water retention and symptomatic hyponatraemia in idiopathic diabetes insipidus during chlorpropamide therapy (Q36809070) (← links)
- Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus (Q36811751) (← links)
- Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus (Q36991459) (← links)
- Inhibition of vasopressin-stimulated prostaglandin E biosynthesis by chlorpropamide in the toad urinary bladder. Mechanism of enhancement of vasopressin-stimulated water flow (Q37048995) (← links)
- An assessment of the value of the initial glucose tolerance test in selection of patients for chlorpropamide treatment. (Q38461749) (← links)
- The early treatment blood sugar as an indication of response to chlorpropamide treatment. (Q38462468) (← links)
- The assay and stability of chlorpropamide in solid dispersion with urea (Q39288413) (← links)
- Letter: Chlorpropamide poisoning and diabetes insipidus (Q39343438) (← links)
- Antilipolytic effect of chlorpropamide in isolated rat hepatocytes (Q39452576) (← links)
- Effect of chlorpropamide on hepatic triglyceride metabolism (Q39452583) (← links)
- Chlorpropamide alcohol flushing and diabetic retinopathy (Q39544812) (← links)
- Association of hyperinsulinemia with chlorpropamide toxicity (Q39626388) (← links)
- A hypothesis for the molecular mechanism of action of chlorpropamide in the treatment of diabetes mellitus and diabetes insipidus (Q39710587) (← links)
- Metabolic effects of hypoglycemic sulfonylureas-VI. Effects of chlorpropamide and carbutamide on ketogenesis and on mitochondrial redox state in the isolated perfused rat liver (Q39946403) (← links)
- Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism (Q39948527) (← links)
- Pure red blood cell aplasia associated with chlorpropamide therapy. Patient summary and review of the literature (Q40066702) (← links)